Sirolimus Conversion for Renal Dysfunction in Liver Transplant Recipients: The Devil Really Is in the Details…

G. J. McKenna; J. F. Trotter

首页> 外文期刊>American Journal of Transplantation >Sirolimus Conversion for Renal Dysfunction in Liver Transplant Recipients: The Devil Really Is in the Details…

【24h】

Sirolimus Conversion for Renal Dysfunction in Liver Transplant Recipients: The Devil Really Is in the Details…

机译：西罗莫司转换在肝移植受者中的肾功能不全：魔鬼确实存在于细节中……

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The authors revisit the current FDA warnings applied to the use of sirolimus in liver transplantation, indicating that they are best considered in the context of comprehensive clinical trial data. See article by Abdelmalek et al on page 694.

机译：作者回顾了当前在肝移植中使用西罗莫司的FDA警告，指出在全面的临床试验数据中最好考虑这些警告。参见第694页Abdelmalek等人的文章。

著录项

来源
《American Journal of Transplantation》 |2012年第3期|521-522|共2页
作者
G. J. McKenna; J. F. Trotter;
展开▼
作者单位

Department of Surgery Baylor University Medical Center Dallas TX;

Annette C and Harold C Simmons Transplant Institute Dallas TX;

Department of Medicine Baylor University Medical Center Dallas TX;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Sirolimus conversion for renal dysfunction in liver transplant recipients: the devil really is in the details…. [J] . G J McKenna, J F Trotter American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons . 2012,第3期

机译：西罗莫司转化治疗肝移植受者肾功能不全：真正的关键在于细节……。
2. Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial. [J] . Shenoy S, Hardinger KL, Crippin J, Transplantation: Official Journal of the Transplantation Society . 2007,第10期

机译：具有肾功能不全的肝移植患者的西罗莫司转化：一项前瞻性，随机，单中心试验。
3. Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus. [J] . Backman L, Reisaeter AV, Wramner L, Clinical transplantation. . 2006,第3期

机译：从钙调神经磷酸酶抑制剂转换为西罗莫司后，肾脏或肝脏移植受者的肾功能。
4. Quantitative Analysis of Adipose Tissue on Chest CT to Predict Primary Graft Dysfunction in Lung Transplant Recipients：A Novel Optimal Biomarker Approach [C] . Yubing Tong, Jayaram K. Udupa, Chuang Wang, SPIE Medical Imaging Conference . 2018

机译：胸部CT脂肪组织定量分析预测肺移植受者的原代移植物功能障碍：一种新型最佳生物标志物方法
5. Gene expression profiles of liver transplant recipients with and without post transplant diabetes mellitus. [D] . Driscoll, Carolyn J. 2005

机译：有和没有移植后糖尿病的肝移植受者的基因表达谱。
6. Cellular and molecular immune profiles in renal transplant recipients after conversion from Tacrolimus to Sirolimus [O] . Lorenzo Gallon, Opas Traitanon, Nedjema Sustento-Reodica, -1

机译：从他克莫司转化为西罗莫司后肾移植受者的细胞和分子免疫特征
7. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function [O] . Christopher J.E. Watson, Alexander E.S. Gimson, Graeme J. Alexander, 2007

机译：随机对照试验从分析素抑制剂（CNI）的后转换 - 基于基于西罗司的免疫抑制，肝移植受者受损肾功能受损

Sirolimus Conversion for Renal Dysfunction in Liver Transplant Recipients: The Devil Really Is in the Details…

摘要

著录项

相似文献

相关主题

期刊订阅